BioAge Labs (BIOA) Other Non Operating Income (2024)
BioAge Labs (BIOA) reported Other Non Operating Income of -$250000.0 for Q1 2024.
BioAge Labs (BIOA) Other Non Operating Income (2024) Analysis & Trends
BioAge Labs (BIOA) has 1 years of Other Non Operating Income data on file, last reported at -$250000.0 in Q1 2024.
- For the quarter ending Q1 2024, Other Non Operating Income changed N/A year-over-year to -$250000.0; the trailing twelve-month figure through Dec 2024 stood at -$250000.0 (changed N/A YoY), and the FY2024 full-year result was -$250000.0, changed N/A from the prior year.
- Other Non Operating Income was little changed at -$250000.0 in Q1 2024.
- In the past five years, Other Non Operating Income ranged from a high of -$250000.0 in Q1 2024 to a low of -$250000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | BioAge Labs | 930.32 Mn | 930.32 Mn | -10.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -250,000.00 |